EPZ015666

News alerts, weekly reports and conference planners

Company:

GSK, Ipsen

Drug class:

PRMT5 inhibitor

Related drugs:

PRMT5 overexpression	Retinoblastoma	PRMT5 overexpression	Retinoblastoma	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D
KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D

Associations
(2)